León J, Vives F, Gómez I, Camacho E, Gallo M A, Espinosa A, Escames G, Acuña-Castroviejo D
Instituto de Biotecnología, Departamento de Fisiología, Universidad de Granada, Spain.
Brain Res Bull. 1998 Mar 15;45(5):525-30. doi: 10.1016/s0361-9230(97)00440-1.
Melatonin attenuates the excitatory response of striatal neurons to sensorimotor cortex (SMCx) stimulation, which may be the basis for its neuroprotective role. Searching for new compounds with melatonin-like properties, the effects of several kynurenine derivatives in the response of the rat striatum to SMCx stimulation were studied using electrophysiological and microiontophoretical techniques. Melatonin iontophoresis (-100 nA) significantly attenuated the striatal excitatory response in 89.4% of the recorded neurons, showing excitatory properties in the other 10.6%. Compound A [2-acetamide-4-(3-methoxyphenyl)-4-oxobutyric acid] (-100 nA) displayed similar attenuating effects (86.7% of neurons inhibited vs. 13.3% excited). Compound B [2-acetamide-4-(2-amine-5-methoxyphenyl)-4-oxobutyric acid] (-100 nA) was more potent than melatonin itself to attenuate the excitatory response in 100% of the recorded neurons. Compound C [2-butyramide-4-(3-methoxyphenyl)-4-oxobutyric acid] (-100 nA) significantly increased the excitatory response in 84.2% of the recorded neurons, showing attenuating effects on the other 15.8% of the neurons. Interestingly, compound C iontophoresis excited the neurons in which melatonin had attenuating properties, whereas it inhibited the neurons showing excitatory responses to melatonin. These data suggest melatonin inverse agonist properties for compound C. Also, the effects of compounds B and C appeared immediately after they were iontophoretized, whereas both melatonin and compound A onset latencies were longer (2-4 min). The lack of latency shown by these melatonin analogs points to the possibility that melatonin itself was metabolized before producing its effects on striatal neurons. The results show a family of structurally-related melatonin analogs that may open new perspectives in search for new neuroprotective agents, including its clinical potentiality.
褪黑素可减弱纹状体神经元对感觉运动皮层(SMCx)刺激的兴奋性反应,这可能是其神经保护作用的基础。为寻找具有类似褪黑素特性的新化合物,利用电生理和微离子电泳技术研究了几种犬尿氨酸衍生物对大鼠纹状体对SMCx刺激反应的影响。褪黑素离子电泳(-100 nA)可使89.4%的记录神经元的纹状体兴奋性反应显著减弱,另外10.6%表现出兴奋性特性。化合物A [2-乙酰胺基-4-(3-甲氧基苯基)-4-氧代丁酸](-100 nA)显示出类似的减弱作用(86.7%的神经元被抑制,13.3%被兴奋)。化合物B [2-乙酰胺基-4-(2-氨基-5-甲氧基苯基)-4-氧代丁酸](-100 nA)在减弱兴奋性反应方面比褪黑素本身更有效,可使100%的记录神经元受到抑制。化合物C [2-丁酰胺基-4-(3-甲氧基苯基)-4-氧代丁酸](-100 nA)可使84.2%的记录神经元的兴奋性反应显著增强,另外15.8%的神经元表现出减弱作用。有趣的是,化合物C离子电泳可使褪黑素具有减弱特性的神经元兴奋,而抑制对褪黑素表现出兴奋性反应的神经元。这些数据表明化合物C具有褪黑素反向激动剂特性。此外,化合物B和C离子电泳后其作用立即出现,而褪黑素和化合物A的起效潜伏期较长(2 - 4分钟)。这些褪黑素类似物缺乏潜伏期表明褪黑素本身在对纹状体神经元产生作用之前可能已被代谢。结果显示了一类结构相关的褪黑素类似物,这可能为寻找新的神经保护剂开辟新的前景,包括其临床潜力。